Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.3029
-0.0076 (-2.45%)
Nov 19, 2025, 3:19 PM EST - Market open
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $7.27 million as of November 19, 2025. Its market cap has increased by 12.30% in one year.
Market Cap
7.27M
Enterprise Value
2.84M
1-Year Change
12.30%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.34M to $7.27M, a decrease of -72.41%. That is a compound annual growth rate of -16.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 7.45M | 13.90% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.56M | 131.14% |
| Dec 31, 2020 | 24.47M | -1.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |